Q1 EPS Forecast for Axsome Therapeutics Increased by Analyst
Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) – Research analysts at Leerink Partnrs increased their Q1 2025 earnings estimates for Axsome Therapeutics in a research report issued to clients and investors on Tuesday, February 18th. Leerink Partnrs analyst M. Goodman now anticipates that the company will post earnings of ($1.31) per share for the quarter, […]
Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) – Research analysts at Leerink Partnrs increased their Q1 2025 earnings estimates for Axsome Therapeutics in a research report issued to clients and investors on Tuesday, February 18th. Leerink Partnrs analyst M. Goodman now anticipates that the company will post earnings of ($1.31) per share for the quarter, […]
